Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis

Clinical trial NCT03293173 · UNKNOWN

Trial details

NCT number: NCT03293173
Sponsor: Nordic Lymphoma Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse

Start date: 2017-08-04
Primary completion: 2021-01-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.